A stroke is a devasting occurence in the life of a family. After damage is assessed, the patient, family emembers, caregivers, doctors and friends collaborate on rehabilitation. It is important to understand what kind of stroke the patient suffered and what kinds of physical, neural and nutritional therapies can help to restore normal functioning. This entry in North Atlantic's Family Health Series is a guide to the causes and consequences of a stroke. It outlines a systematic plan to help restore normal living developed by healthcare professionals active in Australia stroke support groups. They are joinded by a Feldenkrais practitioner and a naturopathic physician who describe bodywork and nutritional approaches to complement conventional medicine. After a Stroke will help you understand limitations, effects and recovery prognosis of different kinds of strokes; locate movement therapies and body work to stimulate and re-educate the brain and neural-limb coordination; organize a "health team" blending the best of current orthodox medicine with the bext of traditional, natural therapies; and chart daily patient progress with worksheets, charts and tables.
A stroke is a devasting occurence in the life of a family. After damage is assessed, the patient, family emembers, caregivers, doctors and friends collaborate on rehabilitation. It is important to understand what kind of stroke the patient suffered and what kinds of physical, neural and nutritional therapies can help to restore normal functioning. This entry in North Atlantic's Family Health Series is a guide to the causes and consequences of a stroke. It outlines a systematic plan to help restore normal living developed by healthcare professionals active in Australia stroke support groups. They are joinded by a Feldenkrais practitioner and a naturopathic physician who describe bodywork and nutritional approaches to complement conventional medicine. After a Stroke will help you understand limitations, effects and recovery prognosis of different kinds of strokes; locate movement therapies and body work to stimulate and re-educate the brain and neural-limb coordination; organize a "health team" blending the best of current orthodox medicine with the bext of traditional, natural therapies; and chart daily patient progress with worksheets, charts and tables.
Chapter 23. Animal Models of Stroke Versus Clinical Stroke: Comparison of Infarct Size, Cause, Location, Study Design, and Efficacy of Experimental Therapies
Chapter 23. Animal Models of Stroke Versus Clinical Stroke: Comparison of Infarct Size, Cause, Location, Study Design, and Efficacy of Experimental Therapies
A quantitative and qualitative comparison of contemporary neuroprotection and thrombolytic stroke trials and their preclinical animal counterparts has been undertaken, with meta-analysis (DerSimonian and Laird, 1986) used to evaluate imaging and histological outcomes. Results from 35 clinical trials including 5,532 patients were compared with data from 3,145 pre-clinical acute-stroke experiments in 45,476 animals. While clinical trials tended to be of higher methodological quality and have larger sample sizes than animal experiments (71 patients vs. 7 animals per group), both were similarly underpowered owing to the greater variability in human stroke (average standard deviation of mean in humans 99% v 30% in animals). Proportionally, animal infarcts were almost four times larger than human infarcts in untreated control groups (27% v 8% of the hemisphere) although there was considerable variability in size owing to comorbidities and stroke type. Eighty-six percent of animal studies and 54% of clinical trials reported smaller infarcts in groups receiving treatment, with 41% of clinical trials reporting an improvement in the pre-specified hypothesis. Animal experiments were not effective in predicting individual trial results, nor the level of neuroprotection, however, there was a fair agreement between the direction of the animal and clinical outcomes when looking at the overall direction of drug outcome. As a drug screening tool, experimental stroke studies need refinement. Rational frameworks for translational research will help.
The new third edition of Pediatric Stroke and Cerebrovascular Disorders provides a modern clinical approach to managing stroke and other cerebrovascular problems in infants, children, and adolescents. Incorporating data from important clinical trials and case series, recommendations from the American Heart Association evidence-based paper on the management of pediatric stroke, and the latest information on new diagnostic techniques, the book offers a comprehensive analysis of the current thinking and practice by three physicians who have vast clinical experience in this challenging field. The third edition of this classic work has been completely updated and rewritten to reflect current science and practice. Covering occurrence, etiology, diagnosis, and treatment, this integrated state-of-the-art text is essential reading for anyone involved in the care of children with suspected stroke or other cerebrovascular abnormalities. The third edition of this classic work has been completely updated and rewritten to reflect current science and practice. An extensive, entirely new chapter on treatment provides specific guidance on when to use antiplatelet agents, anticoagulants, and thrombolytic agents in children and also includes a section on neurorehabilitation after stroke. An expanded and thoroughly updated diagnostic approach chapter covers the latest applications in stroke imaging such as computed tomography angiography, diffusion weighted MRI, and perfusion CT. The first chapter stresses the etiology and pathophysiology of childhood stroke as the basis for evaluations and treatment. Features of Pediatric Stroke and Cerebrovascular Disorders, Third Edition Include: Comprehensive in scope: detailed analysis of the pathogenesis, diagnosis, and treatment of cerebrovascular disorders in children with many evidence-based management guidelines The third edition has been updated to include recommendations from the AHA consensus guidelines All chapters in the third edition have been revised and updated An extensive, entirely new chapter on treatment provides specific guidance on when to use antiplatelet agents, anticoagulants, and thrombolytic agents in children Stresses the etiology and pathophysiology of childhood stroke as the basis for evaluation and treatment Maintains the practical, clinical flavor established in previous editions, with numerous illustrations and useful suggestions for patient care Written by internationally known stroke experts: Dr. Roach chaired the AHA panel that produced the consensus guidelines on childhood stroke and Drs. Lo and Heyer have published extensively on stroke and related topics
Rev. ed. of: Pediatric cerebrovascular disorders / E.S. Roach, Anthony R. Riela; with a foreword by Roger N. Rosenberg; chapters by Susan T. Iannaccone and Jeffrey Perlman. 1995. 2nd ed.
The consequences of a brain injury can affect all aspects of our lives, including our personality. Brain injuries do not heal like other injuries and symptoms may appear right away or may not be present for days or weeks after the injury. This issue will include Past, Present, and Future of TBI research; Pathophysiology of TBI; Advances in brain imaging of TBI; and many more articles leading up to Degenerative Disease following Traumatic Brain Injury.
The information surveyed in this volulme is designed to provide the clinician with an expert overview of the current state of the art in breast cancer management. It should provide at least a flavor of the major paradigm shift that is occurring in this rapidly evolving field. Breast cancer management is moving away from a "kill or cure" model and advancing toward a model focused on strategies of prevention and of long-term management of breast cancer as a chronic disease. The acceptance of this new paradigm by patients and clinicians alike will represent a major focus for the twenty-first century.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.